Soluble tissue factor and tissue factor pathway inhibitor in cardiovascular disease
- 作者V. TOSCHI
- 卷第5卷
- 期第3期
- 印刷ISSN1538-7933
- 电子ISSN1538-7836
- 文件大小458.83KB
- 发表时间2007
- DOI10.1111/j.1538-7836.2007.02402.x
- 页码472-474
Ambient air pollution and acute myocardial infarctionJ. VERMYLEN; A. NEMMAR; B. NEMERY; M. F. HOYLAERTS · 2005
Recirculated normal platelets adhere to surfaces coated with plasma from patients with immune thrombocytopeniaAzerad, M. A.; Harsfalvi, J.; Deckmyn, H.; Vermylen, J.; Michaux, J. L.; Hoylaerts, M. F. · Blood Coagulation & Fibrinolysis · 1997
αIIbβ3 antagonism vs. antiadhesive treatment to prevent platelet interactions with vascular subendotheliumE. Melis; A. Bonnefoy; K. Daenens; H. Yamamoto; J. Vermylen; M. F. Hoylaerts · 2004
von Willebrand factor A1 domain can adequately substitute for A3 domain in recruitment of flowing platelets to collagenA. BONNEFOY; R. A. ROMIJN; P. A. H. VANDERVOORT; I. VAN ROMPAEY; J. VERMYLEN; M. F. HOYLAERTS · 2006